Orakl Oncology

Recrute en direct

Recherche-développement en autres sciences physiques et naturelles · 10 à 19 salariés employés · VILLEJUIF, FR

orakl-oncology.com LinkedIn 2 offres actives

offres actives

localisation

technologies

À propos

🔮 Less than 5% of new cancer drugs successfully make it through clinical trials. Clearly, new methods are needed to transform oncology research and improve patient care. Orakl Oncology is a techbio startup accelerating drug discovery and development through innovative tumor avatars. The company was established in 2023 as a spin-out from Gustave-Roussy, a leading European cancer research institute based on 10 years of research by Orakl’s CEO, Dr. Fanny Jaulin, and her laboratory.

Secteur: Recherche-développement en autres sciences physiques et naturelles
Effectif: 10 à 19 salariés employés
Siège: VILLEJUIF, FR
Fondée: 2023